Nirmiti Pharmaceutical Private Limited
About Nirmiti Pharmaceutical Private Limited
Data last updated:
Nirmiti Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2019PTC183819. Its GSTIN is 27AAGCN5146H1ZC (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikas Babasaheb Bade and Akshay Ramesh Karad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.05 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.6 Lakh (net margin 2.7%) and EBITDA of ₹3.71 Lakh (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 44% over five years.
Company details
Contact details
Nirmiti Pharmaceutical Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice – 214 2nd Floor Sai Plazza, S.No.113/1 Rahatani, Pune, Maharashtra, India – 411017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nirmiti Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nirmiti Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Nirmiti Pharmaceutical Private Limited, buy the company report.
Financials of Nirmiti Pharmaceutical Private Limited
FY 2025 filings availableNirmiti Pharmaceutical Private Limited reported revenue of ₹60.05 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 6% growth in the latest year. EBITDA rose 690% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nirmiti Pharmaceutical Private Limited, buy the company report.
Board of directors of Nirmiti Pharmaceutical Private Limited
Nirmiti Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Babasaheb Bade | Director | 30 Apr 2019 | 7 Years 6 Months | Current |
| Akshay Ramesh Karad | Director | 30 Apr 2019 | 7 Years 6 Months | Current |
Auditor
Nirmiti Pharmaceutical Private Limited is audited by M D HINGNE & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M D HINGNE & CO. | FY 2024 | 147769W |
Shareholding
The shareholding of Nirmiti Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nirmiti Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nirmiti Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nirmiti Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nirmiti Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCN5146H1ZC | Maharashtra | Active | 09 Aug 2019 |
To see the full GST registrations and return filing status of Nirmiti Pharmaceutical Private Limited, buy the company report.
Recent activity
Nirmiti Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Akshay Ramesh Karad was appointed as Director on 30 Apr 2019.
Frequently asked questions
Nirmiti Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 April 2019 (7+ years old) and is registered under CIN U85100PN2019PTC183819.
Nirmiti Pharmaceutical has 2 current directors:
- Vikas Babasaheb Bade - Director
- Akshay Ramesh Karad - Director
The latest financial statements of Nirmiti Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Nirmiti Pharmaceutical is 27AAGCN5146H1ZC, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Nirmiti Pharmaceutical is U85100PN2019PTC183819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nirmiti Pharmaceutical was incorporated on 30 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Akshay Ramesh Karad was appointed as Director on 30 Apr 2019. Vikas Babasaheb Bade was appointed as Director on 30 Apr 2019.
The registered office of Nirmiti Pharmaceutical is at Office – 214 2nd Floor Sai Plazza, S.No.1131 Rahatani, Pune, Maharashtra, India – 411017.
Nirmiti Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Nirmiti Pharmaceutical can be reached at its registered office: Office – 214 2nd Floor Sai Plazza, S.No.1131 Rahatani, Pune, Maharashtra, India – 411017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
